CoChat

Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors

Open access

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Chronic atrophic autoimmune gastritis (CAAG) can lead to the development of gastric neuroendocrine tumors (gNETs) and can be accompanied by other autoimmune diseases. This study aimed to determine, in CAAG patients, the association of gNET development, the prevalence of autoimmune diseases other than CAAG, the association of autoimmunity, and gNET development with pepsinogen I, II, gastrin-17, and Helicobacter pylori infection analysis. METHODS: We determined the prevalence of gNETs and other autoimmune diseases and analyzed pepsinogen I and II, gastrin-17 serum levels, and H. pylori infection in all patients diagnosed with CAAG at our hospital between 2013 and 2017. RESULTS: A total of 156 patients were studied and in 15.4% was observed concomitant gNET. Approximately 68.6% had at least 1 other autoimmune disease at diagnosis of CAAG. Approximately 60.9% had autoimmune thyroiditis, followed by diabetes (19.9%) and autoimmune polyendocrine syndrome (12.8%). CAAG patients with and without gNET had similar rates of comorbidity with other autoimmune diseases, but the pepsinogen I/II ratio was lower in patients with gNET (1.6 vs 4.5, P = 0.018). Receiver operating characteristic curve analyses identified a pepsinogen I/II ratio <2.3 and gastrin-17 levels >29.6 pmol/L as cutoffs distinguishing CAAG patients with gNET from those without. The combined use of these cutoff correctly identified 16 of the 18 CAAG patients with gNET (P = 0.007). H. pylori infection was observed in 28.7% of cases tested but did not associate with gNET. DISCUSSION: This study suggests that a low pepsinogen I/II ratio and high gastrin-17 levels characterize patients with CAAG and gNET and confirms the frequent coexistence of CAAG with other autoimmune diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14309/ctg.0000000000000238

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Receiver operating characteristic (ROC) curves for serum pepsinogen (PG) I/II ratio (a) and gastrin-17 (b) discriminating chronic atrophic autoimmune gastritis patients with and without gastric neuroendocrine tumors (gNETs). AUC, area under the ROC curve.
Figure 1. Receiver operating characteristic (ROC) curves for serum pepsinogen (PG) I/II ratio (a) and gastrin-17 (b) discriminating chronic atrophic autoimmune gastritis patients with and without gastric neuroendocrine tumors (gNETs). AUC, area under the ROC curve.CC BY · PubMed Central
Figure 2. Gastrin-17 levels among chronic atrophic autoimmune gastritis patients, by pepsinogen (PG) I/II ratio and presence or absence of gastric neuroendocrine tumor (gNET).
Figure 2. Gastrin-17 levels among chronic atrophic autoimmune gastritis patients, by pepsinogen (PG) I/II ratio and presence or absence of gastric neuroendocrine tumor (gNET).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 48

Metadata

Authors
Magris, R., De Re, V., Maiero, S., Fornasarig, M., Guarnieri, G., Caggiari, L., Mazzon, C., Zanette, G., Steffan, A., Canzonieri, V., & Cannizzaro, R.
Affiliations
  • Centro di Riferimento Oncologico (IT)
  • Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy;
  • Azienda Ospedaliera Santa Maria Degli Angeli (IT)
  • University of Trieste (IT)
Corresponding author
Cannizzaro, Renato
Venue
Clinical and Translational Gastroenterology
Published
2020-09
Volume
11
Issue
9
Pages
e00238
ISSN
2155-384X (ISSN-L)
OpenAlex
W3093856850
Cited by
46
References
35
Citations by year
2026: 3 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 6 · 2021: 7
FWCI
4.12
Type
journal article
Language
en
Open access
Locations
  • Clinical and Translational Gastroenterology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
  • Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
Keywords
gastric neuroendocrine tumor, pepsinogen I/II ratio, gastrin-17, Helicobacter pylori infection, autoimmune disease comorbidity, autoimmune thyroiditis, autoimmune polyendocrine syndrome, diabetes mellitus, biomarker cut-off values
MeSH terms
Adolescent, Adult, Aged, Autoimmune Diseases, Diagnosis, Differential, Female, Gastrins, Gastritis, Atrophic, Humans, Male, Middle Aged, Retrospective Studies, ROC Curve, Stomach Neoplasms, Biomarkers, Prevalence, Helicobacter pylori, Helicobacter Infections, Neuroendocrine Tumors, Pepsinogen C, Pepsinogen A, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors. https://app.cochat.ai/papers/10.14309/ctg.0000000000000238
The paper
Magris, R., De Re, V., Maiero, S., Fornasarig, M., Guarnieri, G., Caggiari, L., Mazzon, C., Zanette, G., Steffan, A., Canzonieri, V., & Cannizzaro, R. (2020). Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors. Clinical and Translational Gastroenterology. https://doi.org/10.14309/ctg.0000000000000238

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.